.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Argus Health
Fuji
Express Scripts
UBS
Healthtrust
Dow
Chinese Patent Office
Baxter
Cantor Fitzgerald

Generated: June 24, 2017

DrugPatentWatch Database Preview

MOTRIN Drug Profile

« Back to Dashboard

Which patents cover Motrin, and when can generic versions of Motrin launch?

Motrin is a drug marketed by Mcneil Ped, Mcneil Consumer, Mcneil, and J And J Consumer Inc. and is included in six NDAs.

The generic ingredient in MOTRIN is ibuprofen. There are sixty-three drug master file entries for this compound. Two hundred and fifty-four suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.

Summary for Tradename: MOTRIN

Patents:0
Applicants:4
NDAs:6
Bulk Api Vendors: see list109
Clinical Trials: see list28
Patent Applications: see list9,697
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MOTRIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mcneil Ped
MOTRIN
ibuprofen
TABLET;ORAL020418-001Nov 16, 1994DISCNNoNo► Subscribe► Subscribe
Mcneil Consumer
MOTRIN
ibuprofen
TABLET;ORAL017463-004Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Mcneil Consumer
MOTRIN
ibuprofen
SUSPENSION;ORAL019842-001Sep 19, 1989DISCNYesNo► Subscribe► Subscribe
Mcneil Consumer
MOTRIN
ibuprofen
TABLET;ORAL017463-005May 22, 1985DISCNYesNo► Subscribe► Subscribe
Mcneil Ped
MOTRIN
ibuprofen
TABLET, CHEWABLE;ORAL020135-001Nov 16, 1994DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: MOTRIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mcneil Ped
MOTRIN
ibuprofen
TABLET, CHEWABLE;ORAL020135-002Nov 16, 19945,320,855*PED► Subscribe
Mcneil Ped
MOTRIN
ibuprofen
TABLET, CHEWABLE;ORAL020135-001Nov 16, 19945,215,755*PED► Subscribe
Mcneil Consumer
MOTRIN
ibuprofen
SUSPENSION;ORAL019842-001Sep 19, 19895,374,659*PED► Subscribe
Mcneil Ped
MOTRIN
ibuprofen
TABLET, CHEWABLE;ORAL020135-002Nov 16, 19945,215,755*PED► Subscribe
Mcneil Ped
MOTRIN
ibuprofen
TABLET, CHEWABLE;ORAL020135-001Nov 16, 19945,320,855*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Citi
Fish and Richardson
Argus Health
Merck
Deloitte
McKesson
Queensland Health
Colorcon
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot